Drug Master Files for: Allergan
✉ Email this page to a colleague
Allergan Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
10732 | I | II | 11/29/1993 | ALLERGAN INC | MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN PUERTO RICO. |
11086 | I | II | 9/16/1994 | ALLERGAN INC | MANUFACTURING SITE, FACILITIES, PERSONNEL AND GENERAL OPERATING PROCEDURES IN WACO, TEXAS. |
1351 | I | II | 4/8/1969 | ALLERGAN PHARMACEUTICAL | MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES OF OPTHALMIC PREPS IN IRVINE, CALIFORNIA. |
2091 | I | IV | 4/2/1973 | ALLERGAN PHARMACEUTICAL | GSH-1157-1738 ENZYME--CLEANING FORMULATION FOR POLYHEMA SOFT LENSES |
2380 | I | II | 12/20/1974 | ALLERGAN PHARMACEUTICAL | GSH-1157-2333X PROLASE 300 (SOFT CONTACT LENS CLEANER) |
2461 | I | III | 6/16/1975 | ALLERGAN INC | PLASTIC COMPONENTS |
27509 | I | II | 1/9/2004 | ALLERGAN INC | BOTOX (R) (BOTULINUM TOXIN A) PURIFIED NEUROTOXIN COMPLEX |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information